NHS performance schemes having little impact, says report

November 28, 2012 in Health

NHS performance schemes having little impact, says report

Enlarge

Many of the controversial incentive schemes aimed at improving quality of service in the NHS may not be working as intended, a major new study has warned.

According to a report produced for the Department of Health by Nottingham University Business School, a number of so-called Best Practice Tariffs have had little or no impact on performance or standards.

Researchers did find evidence of some initiatives having a positive effect—in one case reporting 'significant' improvements—but said the extent was often limited. Some schemes also risked inviting 'unforeseen consequences', including hospitals basing certain on how much money they might earn.

Professor Ruth McDonald, who led the study, said the findings highlighted the need to devise and target such initiatives more carefully.

'Damp squib'

"The overall message is that BPTs can be used to incentivise hospitals but there's a lot of room for improvement," said Professor McDonald.

"In some respects these policies have proved a damp squib. In many cases, despite all of the , providers simply didn't leap to improve their services. Of course, there's an argument that the provision of decent care shouldn't need incentivising in the first place. Some critics even regard these schemes as ''.

"Even so, the fact is that some hospitals are still providing sub-optimal care and, in spite of these schemes, the benefits for their patients have yet to materialise."

The research, carried out in collaboration with the University of Manchester's Institute for , looked at four BPT initiatives.

The first of their kind in this country, they were introduced in April 2010 in an effort to improve performance in selected high-volume clinical treatments in the NHS.

Quality of care was assessed by comparing Hospital Episode Statistics data for the three financial years prior to their introduction to the first financial year afterwards.

Perverse incentives

A scheme to speed up gallbladder operations was found to have resulted in the number of patients treated on a "day case" basis rising by seven percentage points. But some senior employees interviewed for the study were critical of the concept, with one claiming it rewarded 'kicking patients out rather than letting them sleep'.

Another said: "If you don't do the procedure in the morning list you're not going to get Best Practice for it, because they need to stay eight hours after the procedure. If they have the operation at four in the afternoon we're not going to let them out at midnight. You don't want to just push people out of hospital as fast as possible."

Concerns were also raised that BPTs for stroke care and hip surgery could give rise to 'perverse incentives' that might leave some patients facing longer waiting times.

One physician involved in the stroke scheme—for which no evidence of impact was found—described how the prospect of extra income might influence decisions.

He told researchers: "You've got a patient who comes in at 8.30 today. I need to get their CT [scan] done by 8.29 tomorrow, but I can't. Then another patient comes in. Now I've got one slot available. Whose CT do you think I'll do – the one where I can earn £343 for the Trust, not the poor chap who's missed by a few minutes?"

In spite of similar concerns about unintended consequences, the study reported 'significant process quality and outcomes gains' for the hip-operation scheme.

Effort-reward balance

But an initiative intended to improve cataract treatments was largely shunned because the associated bureaucratic demands were considered too complicated.

Professor McDonald, a Professor of Healthcare Innovation and Learning, said the study showed many hospitals were slow to take up and prioritise BPT schemes.

She added: "It's important to recognise that these kinds of schemes are by no means confined to the NHS. Similar ideas are being implemented all around the world. Inevitably, the question that's most often asked is: 'Do they work?' But that's the wrong question, because it fails to acknowledge that these initiatives are all different.

"What we need to do, as we have here, is look at the features of individual schemes and assess the impact in each case to determine how well they function.

"As the Department of Health appreciates, this sort of independent evaluation is vital if we want to learn lessons about particular initiatives and approaches in general."

The report recommends future BPT programmes should target high-volume treatments for which standards in performance clearly vary across the country. It also says treatments for which existing data collection systems, quality initiatives and evidence-based standards are already in place should be given priority.

Professor McDonald said: "Going forward, it's important to focus BPTs on areas where efforts will be outweighed by rewards in terms of patient benefits."

Provided by University of Nottingham search and more info website

not rated yet  

Rank not rated yet
Relevant PhysicsForums posts

More news stories

Life expectancy gap widens between those with mental illness and general population

The gap between life expectancy in patients with a mental illness and the general population has widened since 1985 and efforts to reduce this gap should focus on improving physical health, suggest researchers in a paper ...

Health created 9 hours ago | popularity not rated yet | comments 0

Failure to use linked health records may lead to biased disease estimates

Failure to use linked electronic health records may lead to biased estimates of heart attack incidence and outcome, warn researchers in a paper published in BMJ today.

Health created 9 hours ago | popularity 5 / 5 (1) | comments 0

Dietary advice on added sugar is damaging our health, warns heart expert

Dietary advice on added sugar is damaging our health, warns a cardiologist in BMJ today. Dr. Aseem Malhotra believes that "not only has this advice been manipulated by the food industry for profit but it is actually a risk ...

Health created 9 hours ago | popularity 5 / 5 (4) | comments 0

CDC presents recent trends in health behaviors of US adults

(HealthDay)—In 2008 to 2010, the prevalence of key health behaviors among U.S. adults varied, with about one in five adults current smokers and 62.1 percent overweight or obese, according to a report presented ...

Health created 12 hours ago | popularity 5 / 5 (1) | comments 0

Americans still making unhealthy choices, CDC reports

(HealthDay)—The overall health of Americans isn't improving much, with about six in 10 people either overweight or obese and large numbers engaging in unhealthy behaviors like smoking, heavy drinking or ...

Health created 12 hours ago | popularity not rated yet | comments 0


Phthalates: Study links chemicals widely found in plastics, processed food to elevated blood pressure in children, teens

Plastic additives known as phthalates (pronounced THAL-ates) are odorless, colorless and just about everywhere: They turn up in flooring, plastic cups, beach balls, plastic wrap, intravenous tubing and—according to the ...

If you can remember it, you can remember it wrong

(Medical Xpress)—Native peoples in regions where cameras are uncommon sometimes react with caution when their picture is taken. The fear that something must have been stolen from them to create the photo ...

B vitamins could delay dementia

(Medical Xpress)—Despite spending billions of dollars on research and development, drug companies have been unable to come up with effective treatments for dementia and Alzheimer's Disease (AD). Now, A. ...

Insight into the dazzling impact of insulin in cells

Australian scientists have charted the path of insulin action in cells in precise detail like never before. This provides a comprehensive blueprint for understanding what goes wrong in diabetes.

New sleeping pill poised to hit US markets

An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.

Reducing caloric intake delays nerve cell loss

Activating an enzyme known to play a role in the anti-aging benefits of calorie restriction delays the loss of brain cells and preserves cognitive function in mice, according to a study published in the May ...